Published 9 days ago • loading... • Updated 9 days ago

Arbutus Biopharma: Moderna Validates My IP Bull Case (NASDAQ:ABUS)

Arbutus (ABUS) looks stronger after Moderna validates its LNP patents, with imdusiran showing durable viral control and a solid runway—read now.

Arbutus (ABUS) looks stronger after Moderna validates its LNP patents, with imdusiran showing durable viral control and a solid runway—read now.

9 days ago·Ra'anana, Israel

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Total News Sources1

Leaning Left0Leaning Right1Center0Last Updated9 days agoBias Distribution

100% Right

100% Right

To view factuality data please Upgrade to Premium

To view ownership data please Upgrade to Vantage

Seeking Alpha broke the news in Ra'anana, Israel 9 days ago on Monday, July 13, 2026.

Sources are mostly out of (0)